Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
112 USD | -1.03% | +0.72% | -8.93% |
13/05 | US reclassification could drive fresh research funding into pot sector | RE |
07/05 | Jazz Pharmaceuticals Insider Sold Shares Worth $548,250, According to a Recent SEC Filing | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-8.93% | 7.06B | |
+30.55% | 588B | |
-3.42% | 364B | |
+18.02% | 326B | |
+4.27% | 285B | |
+14.77% | 239B | |
+9.79% | 210B | |
-7.48% | 200B | |
+8.12% | 167B | |
-1.42% | 161B |
- Stock Market
- Equities
- JAZZ Stock
- News Jazz Pharmaceuticals plc
- Cantor Fitzgerald Cuts Jazz Pharmaceuticals' Price Target to $180 From $210, Keeps Overweight Rating